Defective Drugs:
Reglan Receives Black Box Warning for Tardive Dyskinesia
Reglan
Reglan (generic: metoclopramide) is a prescription drug used to treat gastrointestinal disorders including acid reflux disease, gastroesophageal reflux disease and diabetic gastroparesis. Prescribed to more than 2 million Americans, Reglan received a black box warning from the FDA. The Reglan black box warning states that those taking Reglan (metoclopramide) for long-term treatment or in high doses are at risk for a neurological disorder known as tardive dyskinesia.
If you or a loved one has developed tardive dyskinesia after taking Reglan or other metoclopramide-containing drugs, you may be entitled to financial compensation. Fill out our free case review form today to find out if you can participate in a Reglan lawsuit.
Tardive Dyskinesia: Reglan Neurological Side Effects
Tardive dyskinesia is a disorder that causes involuntary movements of the face and extremities. Symptoms of this Reglan side effect include facial grimacing, lip smacking, lip puckering, tongue thrusting, rapid eye blinking and abnormal movements of the face, mouth, hands, arms, fingers and legs. In some cases, patients with tardive dyskinesia may also experience trouble swallowing, talking, walking and breathing. Currently, there is no treatment for tardive dyskinesia and the symptoms are rarely reversible. Patients at greatest risk for Reglan tardive dyskinesia include the elderly, particularly older women, and those taking metoclopramide-containing drugs for long periods of time.
Experiencing neurological side effects of Reglan? Our Reglan lawyers would like to hear from you. Fill out our free case evaluation form today.
Reglan Class Action Lawsuit
Reglan lawsuits have alleged that the manufacturers of metoclopramide-containing drugs did not adequately explain the drug’s side effects and uses. Many physicians were unaware that these drugs are only intended for short-term treatment (no more than 3 months) when conventional methods fail. However, reports have suggested that one-third of patients took Reglan for a year or longer.
Reglan and metoclopramide-containing drugs can be injected to prevent chemotherapy-related and post-operative nausea and vomiting. The drug can also be orally administrated through a syrup or tablet form to treat gastrointestinal disorders. If you or a loved one has taken this drug and developed tardive dyskinesia, you may be able to recover financial compensation through a Reglan lawsuit. To find out if you are eligible, fill out the free, no obligation case review form today.